Abstract
With an experimental model of spontaneous lung metastases of melanoma developed in this laboratory, a range of sublines (variants and clones) with different metastatic potential and ganglioside expression was established from a single human melanoma cell line M4Be. Using anin vitro clonogenic assay and provided that cells were cultured for no more than five passages, variations in cellular radioresistance of M4Be and seven sublines derived from M4Be were detected. This study shows a positive correlation between the cell intrinsic radioresistance of M4Be and its seven sublines and their total ganglioside content. More precisely, the proportion of radioresistant cells in M4Be and the seven sublines correlated with the number of cells determined by flow cytometry that were positively labelled with a monoclonal antibody directed to GD3 disialoganglioside. Blocking the cellular biosynthesis of gangliosides with the inhibitor Fumonisin B1 or cleaving withVibrio cholerae neuraminidase the cell surface ganglioside-bound sialic acid in a radioresistant poorly metastatic subline increased its radiosensitivityin vitro. In contrast, enrichment of a radiosensitive metastatic subline with exogenous bovine brain GM1 increased its radioresistancein vitro. These results suggest that, in the radiation dose range important for radioprotection (0–1 Gy), membrane gangliosides radioprotect human melanoma cellsin vitro.
Similar content being viewed by others
References
Grdina DJ, Basic I, Mason KA, Withers HR (1975)Rad Res 63: 483–93.
Hill HZ, Hill GJ, Miller CF, Kwong F, Purdy J (1979)Rad Res 80: 259–76.
Leith JT, Dexter DL, Dewyngaert JK, Zeman EM, Chu MY, Calabresi P, Glicksman AS (1982)Cancer Res 42: 2556–61.
Welch DR, Milas L, Tomasovic SP, Nicolson GL (1983)Cancer Res 43: 6–10.
Yang X, Darling JL, McMillan TJ, Peacock JH, Steel GG (1991)Int J Rad Oncol Biol Physics 22: 103–8.
Buronfosse A, Thomas CP, Ginestet C, Doré JF (1994)C R Acad Sci Paris 317: 1031–41.
Fidler IJ (1973)Nature 242: 148–49.
Bailly M, Doré JF (1991)Int J Cancer 49: 750–57.
Suit H, Allam A, Allalunis-Turner J, Brock W, Girinsky T, Hill S, Hunter N, Milas L, Pearcey R, Peters L, Welch DR, West C, Efird J (1994)Cancer Res 54: 1736–41.
Thomas CP, Buronfosse A, Portoukalian J, Fertil B (1995)Cancer Lett 88: 221–25.
Ramakrishnan N, McClain DE, Catravas GN (1993)Int J Rad Biol 63: 693–701.
Kono K, Tsuchida T, Kern DH, Irie R (1990)Cancer Invest 8: 161–67.
Haimovitz-Freidman A, Kan CC, Ehleiter D, Persaud RS, Mclloughlin M, Fuks Z, Kolesnick RN (1994)J Exp Med 180: 525–35.
Zebda N, Pedron S, Rebbaa A, Portoukalian J, Berthier-Vergnes O (1995)FEBS Lett 362: 161–64.
Bailly M, Bertrand S, Doré JF (1991)Int J Cancer 49: 457–66.
Portoukalian J, Carrel S, Doré JF, Rümke P (1991)Int J Cancer 49: 893–99.
Portoukalian J, Bouchon B (1986)J Chromatogr 380: 386–92.
Bouchon B, Portoukalian J, Madec AM, Orgiazzi J (1990)Biochim Biophys Acta 1051: 1–5.
Jourdian GW, Dean L, Roseman S (1971)J Biol Chem 246: 430–35.
Bailly M, Bertrand S, Doré JF (1993)Melanoma Res 3: 51–61.
Fertil B, Dertinger H, Courdi A, Malaise EP (1984)Rad Res 99: 73–84.
Harel R, Futerman AH (1993)J Biol Chem 268: 14476–81.
Manev H, Favaron M, Vicini S, Guidotti A, Costa E (1990)J Pharmcol Exp Ther 252: 419–27.
Koike T, Fehsel K, Zielasek J, Kolb H, Burkart V (1993)Immunol Lett 35: 207–12.
Ferrari G, Anderson BL, Stephens RM, Kaplan DR, Greene LA (1995)J Biol Chem 270: 3074–80.
Hakomori SH (1990)J Biol Chem 265: 18713–16.
Cheresh DA, Pierschbacher MD, Herzig MA, Mujoo K (1986)J Cell Biol 102: 688–96.
Rebbaa A, Bremer E, Portoukalian J (1995)Trends Glycosc Glycotechnol 7: 223–34.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomas, C.P., Buronfosse, A., Combaret, V. et al. Gangliosides protect human melanoma cells from ionizing radiation-induced clonogenic cell death. Glycoconjugate J 13, 377–384 (1996). https://doi.org/10.1007/BF00731470
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731470